20925 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals Lectins
METHOD FOR TREATING X-LINKED RETINOSCHISIS
#2STABILIZED FORMULATION COMPRISING RECOMBINANT STABILIZED GALECTIN 9 PROTEIN
#3PHARMACEUTICAL COMPOSITION, COMPRISING RECOMBINANT STABILIZED GALECTIN 9 PROTEIN, FOR PREVENTION OR TREATMENT OF RHEUMATOID ARTHRITIS AND BONE DISEASE
#4TUMOR-INTRINSIC GALECTIN-3 SUPPRESSES MELANOMA METASTASIS
#5COMPOSITION FOR PREVENTING OR TREATING LUPUS COMPRISING RECOMBINANT STABILIZED GALECTIN-9 PROTEIN
#6OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES
#7TNFSF-L Fusion Proteins and Uses Thereof
#8RECOMBINANT PROTEINS, COMPOSITIONS AND METHODS OF STABILIZATION THEREOF
#9Materials and Methods for Therapy of the Musculoskeletal System and Other Tissues
#10Trim proteins and galectins cooperate and codirect autophagy and are useful in the treatment of autophagy related diseases
#11ANTI-INFLAMMATORY SIGLEC PROTEINS AND METHODS OF MAKING AND USING SAME
#12PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING RECOMBINANT STABILIZED GALECTIN 9 PROTEIN
#13OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES
#14RESPIRATORY VIRUS THERAPEUTIC COMPOSITIONS AND METHODS OF PREPARATION AND USE
#15PEPTIDE DESIGN AND GALECTIN-3 INHIBITORS
#16MICROEMULSION DRUG DELIVERY SYSTEM FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME
#17MANNOSE-BINDING LECTIN FOR TREATMENT OR PROPHYLAXIS OF INFECTIOUS DISEASES
#18Application of TFF2 Protein and IFN-k Protein Combination in Treatment of a Novel Coronavirus Infection
#19GALECTIN-1 IMMUNOMODULATION AND MYOGENIC IMPROVEMENTS IN MUSCLE DISEASES AND AUTOIMMUINE DISORDERS
#20Therapies for B cell malignancies
#21PHARMACEUTICAL COMPOSITION, COMPRISING RECOMBINANT STABILIZED GALECTIN 9 PROTEIN, FOR PREVENTION OR TREATMENT OF RHEUMATOID ARTHRITIS AND BONE DISEASE
#22Combinatorial Apparatus for Disease Management
#23OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES
#24Integrated COVID-19 Strategies
#25METHODS AND COMPOSITIONS FOR PREVENTING, TREATING, AND REVERSING LIVER FIBROSIS
#26GALECTIN-1 IMMUNOMODULATION AND MYOGENIC IMPROVEMENTS IN MUSCLE DISEASES AND AUTOIMMUNE DISORDERS
#27GALECTINS CONTROL MTOR IN RESPONSE TO ENDOMEMBRANE DAMAGE AND PROVIDE A MECHANISM AND TARGET FOR THE TREATMENT OF AUTOPHAGY-RELATED DISEASES
#28TUBULAR NANOSTRUCTURE TARGETED TO CELL MEMBRANE
#29Methods and compositions for preventing and treating damage to the heart
#30LECTIN-BOUND BACTERIA AND USES THEREOF
#31OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES
#32Endocytosis enhancer for drug delivery system
#33GALECTIN IMMUNOTHERAPY
#34Surfactant protein D for the treatment of disorders associated with lung injury
#35Compositions and methods for treating cancers
#36CYP-P22 biocatalytic nanoparticles with cytochrome P450 activity for prodrug activation
#37REVERSAL OF LATENCY OF RETROVIRUSES WITH A GALECTIN PROTEIN
#38INSULIN INDEPENDENCE AMONG PATIENTS WITH DIABETES UTILIZING AN OPTIMIZED HAMSTER REG3 GAMMA PEPTIDE
#39Therapeutic modulation of skin immune system with Gal-7
#40Methods and compositions for preventing and treating damage to the heart
#41CHEMOREPULSION OF CELLS
#42Ophthalmic compositions and methods for treating eyes
#43Lectins and uses thereof
#44Carbosilane dendrimer and aggregatable carrier obtained using said dendrimer for drug delivery system
#45METHODS FOR DIAGNOSING, PROGNOSING AND TREATING MUSCULAR DYSTROPHY
#46Lymphangiogenesis inhibitors for cancer and for graft survival
#47Tubular nanostructure targeted to cell membrane
#48Surfactant protein D for the treatment of disorders associated with lung injury
#49Probiotic function of human intelectin
#50Proteolytic extract from bromelain for the treatment of connective tissue disorders
#51GALECTIN-9-SECRETING CELL, AND PRODUCTION METHOD AND USE OF THE SAME
#52Compositions and methods to treat inflammatory joint disease
#53Ophthalmic compositions and methods for treating eyes
#54Galectin-3C combination therapy for human cancer
#55Insulin independence among patients with diabetes utilizing an optimized hamster Reg3 gamma peptide
#56Insulin independence among patients with diabetes utilizing an optimized hamster REG3 gamma peptide
#57Insulin independence among patients with diabetes utilizing an optimized hamster Reg3 gamma peptide
#58Insulin independence among patients with diabetes utilizing an optimized hamster Reg3 gamma peptide
#59Insulin independence among patients with diabetes utilizing an optimized hamster REG3 gamma peptide
#60Compositions and uses of lectins
#61Method and composition of inducing hair follicle neogenesis
#62NOVEL METHODS OF USE OF BIOMIMETIC PROTEOGLYCANS
#63Systems, devices, and methods for treating a pulmonary disorder with an agent
#64GALECTIN-3 INHIBITOR (GAL-3M) IS ASSOCIATED WITH ADDITIVE ANTI-MYELOMA AND ANTI-SOLID TUMOR EFFECTS, DECREASED OSTEOCLASTOGENESIS AND ORGAN PROTECTION WHEN USED IN COMBINATION WITH PROTEASOME INHIBITORS
#65Methods for diagnosing, prognosing and treating muscular dystrophy
#66HIP/PAP protein and derivatives thereof for use in treating cancer
#67Galectin-3 to Treat Ovarian Cancer
#68METHODS OF INHIBITING ADVERSE CARDIAC EVENTS AND TREATING ATHEROSCLEROSIS AND CORONARY ARTERY DISEASE USING GALECTIN-3 BINDING PROTEIN (GAL-3BP, BTBD17B, MAC-2 BINDING PROTEIN)
#69Lectin conjugates for mucin hydration
#70Ophthalmic compositions and methods for treating eyes
#71Galectin-3C combination therapy for human cancer
#72Surfactant protein D for the treatment of disorders associated with lung injury
#73Treatment method for microbial infection
#74Methods for increasing the embryo implantation rate in mammals
#75OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES
#76Methods for treating muscular dystrophy
#77COMPOSITIONS AND USES OF LECTINS
#78SURFACTANT PROTEIN D FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH LUNG INJURY
#79SPRAY-DRIED COLLECTIN COMPOSITIONS AND PROCESS FOR PREPARING THE SAME
#80NOVEL APPLICATIONS OF HIP/PAP OR DERIVATIVES THEREOF
#81METHODS OF INHIBITING ADVERSE CARDIAC EVENTS AND TREATING ATHEROSCLEROSIS AND CORONARY ARTERY DISEASE USING GALECTIN-3 BINDING PROTEIN (GAL-3BP, BTBD17B, MAC-2 BINDING PROTEIN)
#82Tubular nanostructure targeted to cell membrane
#83METHODS FOR MODULATING A POPULATION OF MYELOID-DERIVED SUPPRESSOR CELLS AND USES THEREOF
#84Compositions comprising E-selectin antagonists and uses therefor
#85METHODS AND COMPOSITIONS FOR MODIFYING T CELL IMMUNE RESPONSES AND INFLAMMATION
#86Treatment Method
#87Treatment of immunocompromised conditions
#88METHODS FOR PREVENTION AND TREATMENT OF INFECTIONS WITH SUPRAPHYSIOLOGICAL DOSES OF MANNAN-BINDING LECTIN (MBL) AND FICOLIN-MBL FUSION PROTEINS
#89Use of Soluble Galectin-3 (Gal-3) for Cancer Treatment
#90Tubular nanostructure targeted to cell membrane
#91Chemorepulsion of cells
#92Tubular nanostructure targeted to cell membrane
#93Tubular nanostructure targeted to cell membrane
#94Composition and Uses of a Galectin for Treatment of Dry Eye Syndrome
#95βGBP, compositions comprising βGBP, and related methods and uses thereof
#96CHEMOREPULSION OF CELLS
#97Methods and compositions for modulating conjunctival goblet cells
#98Spray-dried collectin compositions and process for preparing the same
#99Compositions and uses of a galectin for treatment of dry eye syndrome
#100Ophthalmic compositions and methods for treating eyes
#101Methods for treating conditions associated with lectin-dependent complement activation
#102Agents and methods for treatment of disease by oligosaccharide targeting agents